EPISODE · Jun 29, 2022 · 1H 49M
AUA2022: Surgical & Medical Management of High-Risk Renal Cell Carcinoma
from AUAUniversity · host American Urological Association
Surgical & Medical Management of High-Risk Renal Cell Carcinoma: New Paradigms for Treatment(2022) CME Available: https://auau.auanet.org/node/36065 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Discuss new FDA approved checkpoint inhibitors for treatment and counseling of advanced renal cell carcinoma. 2. Identify indications, risks and benefit of neoadjuvant tyrosine kinase inhibitors for downsizing renal cell carcinoma. 3. Identify appropriate treatment options for management of complex cases.
What this episode covers
Surgical & Medical Management of High-Risk Renal Cell Carcinoma: New Paradigms for Treatment(2022) CME Available: https://auau.auanet.org/node/36065 LEARNING OBJECTIVES At the conclusion of this course, participants will be able to: 1. Discuss new FDA approved checkpoint inhibitors for treatment and counseling of advanced renal cell carcinoma. 2. Identify indications, risks and benefit of neoadjuvant tyrosine kinase inhibitors for downsizing renal cell carcinoma. 3. Identify appropriate treatment options for management of complex cases.
NOW PLAYING
AUA2022: Surgical & Medical Management of High-Risk Renal Cell Carcinoma
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.